Question

Biosimilar involve developing equivalent of biological entity while generics involve developing equivalent of a chemical entity-the active pharmaceutical ingredient (api) biosimilar are extracted from natural sources while generics through chemical synthesis. In case of biosimilar, biological entities being different (and not replica), every organism has to be engineered to produce the same therapeutic effect while in generics, the copies of api can be generated

Answer 1

Answer:

Biosimilar involve developing equivalent of biological entity while generics involve developing equivalent of a chemical entity-the active pharmaceutical ingredient (api) biosimilar are extracted from natural sources while generics through chemical synthesis. In case of biosimilar, biological entities being different (and not replica), every organism has to be engineered to produce the same therapeutic effect while in generics, the copies of api can be generated